Target intelligence / Profile preview

Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C)

Target
TNFRSF10C
Molecular classification
Receptor, TNF receptor superfamily, Decoy receptor, Membrane protein
01

Overview

Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C), also known as Decoy receptor 1 (DCR1) and TRAIL receptor 3 (TRAILR3), is a cell surface receptor in the TNF receptor superfamily. It contains an extracellular cysteine-rich domain that binds TNF-related apoptosis-inducing ligand (TRAIL) but lacks an intracellular death domain required to transmit apoptotic signals. As such, TNFRSF10C does not induce apoptosis after ligand binding but instead functions as a decoy receptor—preventing TRAIL from activating apoptosis through the true death receptors DR4 (TNFRSF10A) and DR5 (TNFRSF10B). TNFRSF10C is considered a negative regulator of apoptosis, and its expression is common in normal tissues but low or absent in many tumor types. Its downregulation, often via promoter hypermethylation, plays a role in tumorigenesis by increasing cell sensitivity to TRAIL-induced cell death. The gene is p53-regulated and inducible upon DNA damage. TNFRSF10C’s status as a decoy receptor makes it of particular interest in cancer immunology, tumor immune evasion, and as a biomarker for various cancers.

Other names
Decoy receptor 1DCR1TRAIL receptor 3TRAILR3LITTRIDCD263Antagonist decoy receptor for TRAIL/Apo-2LDecoy TRAIL receptor without death domainLymphocyte inhibitor of TRAILTNF-related apoptosis-inducing ligand receptor 3TRAIL receptor without an intracellular domain
02

Mechanism of action

Acts as a decoy receptor: binds TRAIL but does not transduce apoptotic signals, thereby blocking apoptosis otherwise mediated by TRAIL-activated death receptors (DR4, DR5).

03

Biological functions

Apoptosis regulationImmune responseProtection from TRAIL-induced apoptosisNegative regulation of death receptor signaling
04

Disease associations

CancerTumorigenesisCancer immune surveillance
05

Safety considerations

Downregulation or hypermethylation in tumors may increase cancer cell susceptibility to TRAIL-induced apoptosis, which could affect both normal and tumoral cells in TRAIL pathway–targeted therapies.The decoy function may potentially confer resistance to TRAIL-based therapies in some tumor types.
06

Interacting drugs

No direct clinical drugs are approved that target TNFRSF10C, but therapies targeting the TRAIL pathway (using TRAIL-R agonists and recombinant TRAIL) indirectly interact with this pathway.
07

Biomarkers

Hypermethylation of the TNFRSF10C promoter (potential diagnostic or prognostic marker in several cancer types, e.g., NSCLC, prostate, breast, and pancreatic cancer)Expression or methylation status potentially useful for liquid/tissue biopsy-based cancer diagnostics

Beyond the preview

Go deeper on Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call